The Scientist

» clinical trials and microbiology

Most Recent

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

image: Antarctic Bacteria Latch Onto Ice with Molecular Fishing Rod

Antarctic Bacteria Latch Onto Ice with Molecular Fishing Rod

By | November 1, 2016

Researchers describe the first known bacterial adhesion molecule that binds to frozen water. 

0 Comments

image: Contributors

Contributors

By | November 1, 2016

Meet some of the people featured in the November 2016 issue of The Scientist.

0 Comments

image: Viruses of the Human Body

Viruses of the Human Body

By | November 1, 2016

Some of our resident viruses may be beneficial.

4 Comments

image: The Human Virome

The Human Virome

By | November 1, 2016

Diverse viruses can be found commingling with human and bacteria cells in and on people’s bodies. Scientists are just beginning to understand how these viruses help and when they can turn pathogenic.

0 Comments

An early-stage study of the effectiveness of a lung-cancer vaccine developed by scientists in Cuba could start as early as next month.

0 Comments

image: European Drug Regulator Releases Clinical Trial Data

European Drug Regulator Releases Clinical Trial Data

By | October 21, 2016

In the initial steps of a campaign to make clinical reports publicly available, the European Medicines Agency has published data on two recently approved drugs.

0 Comments

image: Clinical Trial Database Launches

Clinical Trial Database Launches

By | October 12, 2016

OpenTrials.net seeks to increase transparency and make clinical research more accessible to the public.

0 Comments

image: Deep-Sea Viruses Destroy Archaea

Deep-Sea Viruses Destroy Archaea

By | October 12, 2016

Viruses are responsible for the majority of archaea deaths on the deep ocean floors, scientists show.

4 Comments

image: Pet Meds Adapted from Human Therapies

Pet Meds Adapted from Human Therapies

By | October 1, 2016

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.

0 Comments

Popular Now

  1. Unstructured Proteins Help Tardigrades Survive Desiccation
  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Inflammation Drives Gut Bacteria Evolution
Business Birmingham